                         SEQUENCE LISTING

<110>  Stichting Het Nederlands Kanker Instituut-Antoni van 
       Leeuwenhoek Ziekenhuis
 
<120>  Anti-tumor immunity induces the presentation of aberrant peptides

<130>  P128642PC00

<140>  PCT/NL2021/050629
<141>  2021-10-18

<150>  EP 20202435.2
<151>  2020-10-16

<150>  EP 20214612.2
<151>  2020-12-16

<150>  EP 21166757.1
<151>  2021-04-01

<160>  75    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  model peptide from mouse ovalbumin

<400>  1

Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               


<210>  2
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  2

Leu Ser Leu Glu Glu Gly Ala Gln Ser Gln Leu Thr Thr Ala Met Asp 
1               5                   10                  15      


Tyr Leu Arg 
            


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  3

Gly Pro Ser Ser Ser Pro Gly Gly Ala Asn Pro Val Met Lys 
1               5                   10                  


<210>  4
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  4

Leu Gly Cys Val Leu Ser Gly Asp Thr Pro Gly Leu Leu Pro Ile Pro 
1               5                   10                  15      


Arg 
    


<210>  5
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  5

Ala Ser Leu Met Thr Gly Lys Thr Thr Trp Gln Ser Ser Thr Phe Leu 
1               5                   10                  15      


<210>  6
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  6

Ala Thr Gly Leu Ala Met Ala Ala Thr Thr Thr Arg Pro Met Ala Ile 
1               5                   10                  15      


Thr Ala Thr Ala Pro Ala Thr Thr Thr Val Arg 
            20                  25          


<210>  7
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  7

Ile Ile Glu Pro Ser Pro Thr Thr Arg Pro Ser Ala Ser Leu Ser Asp 
1               5                   10                  15      


Pro Ser Leu Leu Pro Lys Ile Pro Arg 
            20                  25  


<210>  8
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  8

Ala Ala Leu Arg Pro Ala Gly Ala Leu Pro Pro Leu Pro Ala His Leu 
1               5                   10                  15      


Ser Val Pro Ala Ala Arg 
            20          


<210>  9
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  9

Ser Gly His Ala Gln Ala Gly Ala Leu Ser Asp Cys Gly 
1               5                   10              


<210>  10
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  10

Arg Thr Ser Cys Ser Val Gln Thr Ala Ile Pro Thr Ser Thr His Pro 
1               5                   10                  15      


Ser Ala Arg 
            


<210>  11
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  11

Arg Val Pro Thr Cys Met Thr Thr Ala Cys Cys Cys Pro Ala Glu Leu 
1               5                   10                  15      


Thr Ser Ser Glu Gly 
            20      


<210>  12
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  12

Ala Ser His Cys Ile Ala Leu Glu Ala Lys Trp Ser Thr Cys Cys Leu 
1               5                   10                  15      


Tyr Tyr Ser Arg 
            20  


<210>  13
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  13

Cys Leu Ser Val Thr Ser Ser Pro Arg Gly Thr Ser Ala Ser Pro 
1               5                   10                  15  


<210>  14
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  14

Leu Ala Ala Pro Gly His Gln Gly Cys Gly Cys Asp Arg 
1               5                   10              


<210>  15
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  15

Leu Gln His Ser Glu Ala Glu Ile Ser Glu Leu Tyr Ser Ser 
1               5                   10                  


<210>  16
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  16

Thr Leu Pro Leu Lys Leu Leu Thr Thr Lys 
1               5                   10  


<210>  17
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  17

Ala Ala Ala Thr Ser Ala Ala Pro Thr Ser Glu Thr Ser Ile Arg 
1               5                   10                  15  


<210>  18
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  18

Gly Pro Gly Gly Ala Pro Ser Ala Ala Asp Arg Gly Pro Pro Glu Pro 
1               5                   10                  15      


Gln Gly Gln Gln Arg Glu Asp Asp Ser Asp Tyr Val 
            20                  25              


<210>  19
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  19

Ser Pro Leu Ser Thr Gly Asp Arg Cys Ser Pro Ser Pro Val Lys 
1               5                   10                  15  


<210>  20
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  20

Leu Ala Ala Leu Ala Gln Gly Ala Ala Gly Pro Gly Ala His Leu Pro 
1               5                   10                  15      


Asp Gly Ala Ala Ala Ala Arg Pro Gly Ala Gly Ala His Ala Arg 
            20                  25                  30      


<210>  21
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  21

Val Leu Arg Leu Gln His Ser Glu Ala Glu Ile Ser Glu Leu Tyr Ser 
1               5                   10                  15      


Ser 
    


<210>  22
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  22

Gly Ser Val Glu Gly Glu Ser Ala Leu Glu Ala Leu Arg Pro Ala Val 
1               5                   10                  15      


Lys 
    


<210>  23
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  23

Gln Ala Gln Gly Ala Gly Glu Leu Gln Gly Gly Asp Gln Gly Ile Leu 
1               5                   10                  15      


Pro Arg 
        


<210>  24
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  24

Arg Gly Gln Pro Gly Gly Ser Glu Gly Ala Ser Arg Leu Pro Glu Leu 
1               5                   10                  15      


Ser Glu Gly Glu Gly Pro Cys Ala Gly Ser Asn Ser Gln Glu Pro Glu 
            20                  25                  30          


Gly 
    


<210>  25
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  25

Leu Gly Val His Pro Leu Ser Cys His Gly Gly Ser Leu Gly Asn Met 
1               5                   10                  15      


Glu Ile Pro Val Cys Leu Tyr Gly Val Glu 
            20                  25      


<210>  26
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  26

Thr Val Gly Thr Ala Asp His His Gly Pro Met Thr Thr Ser Ser Ser 
1               5                   10                  15      


Gly Gly Leu Pro Thr Arg 
            20          


<210>  27
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  27

Leu Ile Ala Leu Ser Ile Asp Ser Val Glu Asp His Leu Ala Gly Ala 
1               5                   10                  15      


Arg 
    


<210>  28
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  28

Ala Ala Arg Gly Pro Gly Gly Ala Pro Ser Ala Ala Asp Arg Gly Pro 
1               5                   10                  15      


Pro Glu Pro Gln Gly Gln Gln Arg 
            20                  


<210>  29
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  29

Glu Phe Arg Pro Glu Asp Gln Pro Gly Cys Ser Gly Ser Thr Ala Asn 
1               5                   10                  15      


Gln Ala Gly Ser Ser Arg 
            20          


<210>  30
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  30

Ala Ser Cys Gly Pro Gly Pro Ser Gly Cys Gly Ala Leu Ile Pro Lys 
1               5                   10                  15      


<210>  31
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  31

Arg Gln Ala Gln Gly Ala Gly Glu Leu Gln Gly Gly Asp Gln Gly Ile 
1               5                   10                  15      


Leu Pro Arg 
            


<210>  32
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  32

Asn Leu Gln Glu Ala Glu Glu Gly Thr Asn Pro Ser Leu Leu Thr Ser 
1               5                   10                  15      


Leu Arg Leu Pro Thr Gly Thr Met Thr Pro Cys Ala Arg 
            20                  25                  


<210>  33
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  33

Ser Gly Ser Ser Ser Thr Ser Gly Pro Thr Gln Gln Arg 
1               5                   10              


<210>  34
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  34

Ala Lys Glu Glu Ser Ser Gly Cys Ala Gly Cys Pro Lys Val Leu Arg 
1               5                   10                  15      


<210>  35
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  35

Glu Gly His Gly Gly Gly His Pro Ala Ala Ala Pro Pro Gly Gly Ala 
1               5                   10                  15      


Gln Gly Ala Ala Ser Asp His 
            20              


<210>  36
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  36

Leu Gly Gln Leu Pro Gly Ala Glu Gly Gln Ala Glu Ala Gly Ala Pro 
1               5                   10                  15      


Ser Leu Gly Ala Gly Ala Gln Cys Gln Ala Gln Pro Ser Gly Thr His 
            20                  25                  30          


His Cys Arg Glu 
        35      


<210>  37
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  37

His Asn Glu Val Trp Met Val Asp Phe Tyr Ser Pro Gly Val Ile Leu 
1               5                   10                  15      


Ala Lys 
        


<210>  38
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  38

Val Gly Arg Pro Met Gly Met Val Lys Thr Asp Ser Gly Gly Pro Ser 
1               5                   10                  15      


Val Leu Lys 
            


<210>  39
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  39

Ala Ala Gly Gln Ala Gln Gly Thr Ala Leu Leu Gln His Glu Asp Arg 
1               5                   10                  15      


<210>  40
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  40

Glu Gly Gly Lys Ile Glu Met Glu Asn Leu Lys 
1               5                   10      


<210>  41
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  41

Thr Leu Thr Ala Met Ser Val Val Gly Phe Pro Gly Gly Arg 
1               5                   10                  


<210>  42
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  42

Ile Thr Thr Ser His Thr Glu Ala Ala Ala Gly Ala Thr Asn 
1               5                   10                  


<210>  43
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  REV 1 peptide

<400>  43

Met Ile Ser Ser Thr Ser Ser Glu Met Gln Gln Thr Lys 
1               5                   10              


<210>  44
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  REV 2 peptide

<400>  44

Asn Cys Asn Glu Val Val Trp Gln Pro Gly Met Leu Thr Ala Ala Ile 
1               5                   10                  15      


Ile 
    


<210>  45
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  REV 3 peptide

<400>  45

Gln Glu Asp Leu Phe Glu Gln Leu Glu Thr Leu His Ser Ile Asn Glu 
1               5                   10                  15      


Ile 
    


<210>  46
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  46

Val Pro Leu Ser Leu Ala Glu His Ala Leu 
1               5                   10  


<210>  47
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  47

Ser Pro Leu Ser Ser Leu Ser Thr Leu 
1               5                   


<210>  48
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  48

Gln Phe Leu Ala Glu Ile Leu Gln Val 
1               5                   


<210>  49
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  49

Ser Pro Thr Leu Ser Gln Cys Ser Leu 
1               5                   


<210>  50
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  50

Met Val Ser Pro Leu Ala Gly Val Pro Lys 
1               5                   10  


<210>  51
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  51

Val Gly Gln Glu Gly Leu Val Ser Leu 
1               5                   


<210>  52
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  52

Ser Pro Ala Leu Arg Thr Leu Thr Leu 
1               5                   


<210>  53
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  53

Ala Pro Ser Gly Val Ala Ala Gly Leu 
1               5                   


<210>  54
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  54

Leu Phe Leu Ser His Leu Glu Glu Ile 
1               5                   


<210>  55
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  55

Val Ala Ala Ala Glu Ser His Pro Leu 
1               5                   


<210>  56
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  56

Thr Ser Leu Val Asn Leu Ser Thr Leu 
1               5                   


<210>  57
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  frameshifted peptide

<400>  57

Ser Pro Arg Gly Pro Pro Ser Ser Leu 
1               5                   


<210>  58
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RFX1-based peptide

<400>  58

Thr Leu Val Glu Asp Leu Leu Glu Val 
1               5                   


<210>  59
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ILRUN-based peptide

<400>  59

Leu Leu Thr His Gly Leu Leu Leu Leu 
1               5                   


<210>  60
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ETF1-based peptide

<400>  60

Leu Leu Glu Gly Leu Leu Thr Thr Ile 
1               5                   


<210>  61
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RHOBTB3-based peptide

<400>  61

Thr Val Ile Gly Thr Leu Leu Glu Ile 
1               5                   


<210>  62
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SRSF3-based peptide

<400>  62

Gly Leu Leu Glu Thr His Pro Ala Leu Leu Leu 
1               5                   10      


<210>  63
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CNIH4-based peptide

<400>  63

Leu Met Ser Leu His Leu Val His Leu Pro Ser Gln Leu Thr Cys 
1               5                   10                  15  


<210>  64
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  c-myc domain

<400>  64

Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu 
1               5                   10  


<210>  65
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  hemagglutinin tag

<400>  65

Tyr Pro Tyr Asp Val Pro Asp Tyr Ala 
1               5                   


<210>  66
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tryptophan-containing region


<220>
<221>  misc_feature
<222>  (2)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  66

Trp Xaa Xaa Trp 
1               


<210>  67
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tryptophan-containing region


<220>
<221>  misc_feature
<222>  (2)..(4)
<223>  Xaa can be any naturally occurring amino acid

<400>  67

Trp Xaa Xaa Xaa Trp 
1               5   


<210>  68
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tryptophan-containing region


<220>
<221>  misc_feature
<222>  (2)..(5)
<223>  Xaa can be any naturally occurring amino acid

<400>  68

Trp Xaa Xaa Xaa Xaa Trp 
1               5       


<210>  69
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tryptophan-containing region


<220>
<221>  misc_feature
<222>  (2)..(6)
<223>  Xaa can be any naturally occurring amino acid

<400>  69

Trp Xaa Xaa Xaa Xaa Xaa Trp 
1               5           


<210>  70
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tryptophan-containing region


<220>
<221>  misc_feature
<222>  (2)..(7)
<223>  Xaa can be any naturally occurring amino acid

<400>  70

Trp Xaa Xaa Xaa Xaa Xaa Xaa Trp 
1               5               


<210>  71
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tryptophan-containing region


<220>
<221>  misc_feature
<222>  (2)..(8)
<223>  Xaa can be any naturally occurring amino acid

<400>  71

Trp Xaa Xaa Xaa Xaa Xaa Xaa Xaa Trp 
1               5                   


<210>  72
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tryptophan-containing region


<220>
<221>  misc_feature
<222>  (2)..(9)
<223>  Xaa can be any naturally occurring amino acid

<400>  72

Trp Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Trp 
1               5                   10  


<210>  73
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tryptophan-containing region


<220>
<221>  misc_feature
<222>  (2)..(10)
<223>  Xaa can be any naturally occurring amino acid

<400>  73

Trp Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Trp 
1               5                   10      


<210>  74
<211>  28
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  hypothetical RNA template


<220>
<221>  misc_feature
<222>  (1)..(13)
<223>  n is a, c, g, or u

<220>
<221>  misc_feature
<222>  (17)..(28)
<223>  n is a, c, g, or u

<400>  74
nnnnnnnnnn nnnuggnnnn nnnnnnnn                                          28


<210>  75
<211>  28
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  hypothetical RNA template


<220>
<221>  misc_feature
<222>  (4)..(28)
<223>  n is a, c, g, or u

<400>  75
uggnnnnnnn nnnnnnnnnn nnnnnnnn                                          28


